Examined

Examined

Share this post

Examined
Examined
RSV vaccine - a primary care update on serious risks and benefits

RSV vaccine - a primary care update on serious risks and benefits

Old data, plus real world stuff

Ryan McCormick, M.D.'s avatar
Ryan McCormick, M.D.
Oct 11, 2024
∙ Paid
88

Share this post

Examined
Examined
RSV vaccine - a primary care update on serious risks and benefits
30
6
Share

This fall marks the second year that we’ve had Respiratory Syncytial Virus (RSV) vaccines to offer older adults. Chances are you have received one, are eligible to receive one, or have older family/friends who qualify but are wondering what to do. I’ve been fielding lots of questions about the RSV vaccines from patients over the past several weeks… an…

Keep reading with a 7-day free trial

Subscribe to Examined to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Ryan McCormick
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share